Abstract
The volatile anesthetics are widely used in clinical practice today to produce a state of general anesthesia. But despite more than 150 years of use and substantial scientific investigation, the mechanism by which they produce central nervous system depression remains elusive. Complete understanding of the cellular and molecular basis of the anesthetized state produced by volatile anesthetics most likely involves modulation of the activity of ion channel proteins, these macromolecules provide the most likely molecular targets for these agents. Many studies suggest the involvement of GABAergic and glutamatergic receptor systems in mediating the action of volatile anesthetics. Another ionic current found ubiquitously in neuronal tissues, background potassium currents (also known as resting or leak K+ currents), have recently emerged as plausible targets for volatile anesthetics. A unique structural class of K+ channels with two pore-forming sequences in tandem (2P K+ channels) contributes significantly to background K+ currents. The complete identification of all the 2P K+ channel family members has likely been accomplished. Within intact neuronal systems, background K+ channels are responsible for essential inhibition, these actions are enhanced by volatile anesthetics. Thus, members of this family have emerged as strong candidates for the molecular site of volatile anesthetic action.
Keywords: volatile anesthetics, ion channels, background potassium channels, anesthetic mechanisms
Current Drug Targets
Title: Update on Tandem Pore (2P) Domain K+ Channels
Volume: 4 Issue: 4
Author(s): C. Spencer Yost
Affiliation:
Keywords: volatile anesthetics, ion channels, background potassium channels, anesthetic mechanisms
Abstract: The volatile anesthetics are widely used in clinical practice today to produce a state of general anesthesia. But despite more than 150 years of use and substantial scientific investigation, the mechanism by which they produce central nervous system depression remains elusive. Complete understanding of the cellular and molecular basis of the anesthetized state produced by volatile anesthetics most likely involves modulation of the activity of ion channel proteins, these macromolecules provide the most likely molecular targets for these agents. Many studies suggest the involvement of GABAergic and glutamatergic receptor systems in mediating the action of volatile anesthetics. Another ionic current found ubiquitously in neuronal tissues, background potassium currents (also known as resting or leak K+ currents), have recently emerged as plausible targets for volatile anesthetics. A unique structural class of K+ channels with two pore-forming sequences in tandem (2P K+ channels) contributes significantly to background K+ currents. The complete identification of all the 2P K+ channel family members has likely been accomplished. Within intact neuronal systems, background K+ channels are responsible for essential inhibition, these actions are enhanced by volatile anesthetics. Thus, members of this family have emerged as strong candidates for the molecular site of volatile anesthetic action.
Export Options
About this article
Cite this article as:
Yost Spencer C., Update on Tandem Pore (2P) Domain K+ Channels, Current Drug Targets 2003; 4 (4) . https://dx.doi.org/10.2174/1389450033491091
DOI https://dx.doi.org/10.2174/1389450033491091 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Ubiquitous Choline Transporter SLC44A1
Central Nervous System Agents in Medicinal Chemistry Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Recent Advances in Stroke: Molecular Mechanisms, Approaches, and Treatments (Guest Editor: Xin Wang)]
Central Nervous System Agents in Medicinal Chemistry Wnt Signaling Pathway in Schizophrenia
CNS & Neurological Disorders - Drug Targets Inhibition of Amyloid-like Fibril Formation of Trypsin by Red Wines
Protein & Peptide Letters The Role of Cytochrome P450 in Herb-Drug Interactions
Current Pharmacogenomics Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer’s Disease Pathology
Current Alzheimer Research Antioxidant and Anticholinesterase Activities of Some Dialkylamino Substituted 3-Hydroxyflavone Derivatives
Medicinal Chemistry Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Current Alzheimer Research The Biotransformation of Nitrogen Containing Xenobiotics to Lactams
Current Drug Metabolism Unraveling the Action Mechanism of Buyang Huanwu Tang (BYHWT) for Cerebral Ischemia by Systematic Pharmacological Methodology
Combinatorial Chemistry & High Throughput Screening NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease
Current Drug Discovery Technologies Antiangiogenesis for Rheumatoid Arthritis
Current Drug Targets - Inflammation & Allergy Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer's Disease and Other Tauopathies
Current Drug Delivery Increased Alzheimer’s Disease Neuropathology is Associated with Type 2 Diabetes and ApoE ε4 Carrier Status
Current Alzheimer Research The Impact of Pharmaceutical Care Practice on the Practitioner and the Patient in the Ambulatory Practice Setting: Twenty-five Years of Experience
Current Pharmaceutical Design A Novel Cell-based β-secretase Enzymatic Assay for Alzheimer’s Disease
Current Alzheimer Research Post Marketing Surveillance on Safety and Efficacy of IMOD in Iranian Patients with HIV/AIDS
Infectious Disorders - Drug Targets Patients Characteristics and Clinical Implications of Suboptimal CD4 T-Cell Gains After 1 Year of Successful Antiretroviral Therapy
Current HIV Research